WO2015175828A1 - Étalonnage de niveau de substance à analyser à l'aide d'un niveau de substance à analyser de ligne de base - Google Patents

Étalonnage de niveau de substance à analyser à l'aide d'un niveau de substance à analyser de ligne de base Download PDF

Info

Publication number
WO2015175828A1
WO2015175828A1 PCT/US2015/030880 US2015030880W WO2015175828A1 WO 2015175828 A1 WO2015175828 A1 WO 2015175828A1 US 2015030880 W US2015030880 W US 2015030880W WO 2015175828 A1 WO2015175828 A1 WO 2015175828A1
Authority
WO
WIPO (PCT)
Prior art keywords
signal data
analyte
collected
period
time
Prior art date
Application number
PCT/US2015/030880
Other languages
English (en)
Inventor
Udo Hoss
Erwin S. Budiman
Original Assignee
Abbott Diabetes Care Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Abbott Diabetes Care Inc. filed Critical Abbott Diabetes Care Inc.
Priority to EP15793074.4A priority Critical patent/EP3142552B1/fr
Priority to AU2015259020A priority patent/AU2015259020C1/en
Priority to ES15793074T priority patent/ES2905877T3/es
Priority to CA2948652A priority patent/CA2948652C/fr
Priority to US15/310,691 priority patent/US10905364B2/en
Priority to RU2016149127A priority patent/RU2016149127A/ru
Priority to EP21206620.3A priority patent/EP4026496A1/fr
Priority to CN201580025914.6A priority patent/CN106456065B/zh
Publication of WO2015175828A1 publication Critical patent/WO2015175828A1/fr
Priority to US17/149,976 priority patent/US20210128029A1/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/145—Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissue
    • A61B5/1495—Calibrating or testing of in-vivo probes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/145—Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissue
    • A61B5/14532—Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissue for measuring glucose, e.g. by tissue impedance measurement
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/145—Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissue
    • A61B5/14546—Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissue for measuring analytes not otherwise provided for, e.g. ions, cytochromes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/145—Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissue
    • A61B5/1468—Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissue using chemical or electrochemical methods, e.g. by polarographic means
    • A61B5/1473—Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissue using chemical or electrochemical methods, e.g. by polarographic means invasive, e.g. introduced into the body by a catheter
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B2560/00—Constructional details of operational features of apparatus; Accessories for medical measuring apparatus
    • A61B2560/02—Operational features
    • A61B2560/0223—Operational features of calibration, e.g. protocols for calibrating sensors

Abstract

L'invention concerne des procédés, des ordinateurs et des systèmes utilisés pour améliorer la précision de mesure d'un niveau de substance à analyser d'un capteur de substance à analyser in vivo. Les procédés, les ordinateurs et les systèmes de la présente invention peuvent être utilisés pour fournir un niveau étalonné de substance à analyser. Des modes de réalisation spécifiques concernent des procédés, des ordinateurs et des systèmes permettant d'améliorer la précision de la mesure du glucose d'un capteur de glucose positionné in vivo.
PCT/US2015/030880 2014-05-15 2015-05-14 Étalonnage de niveau de substance à analyser à l'aide d'un niveau de substance à analyser de ligne de base WO2015175828A1 (fr)

Priority Applications (9)

Application Number Priority Date Filing Date Title
EP15793074.4A EP3142552B1 (fr) 2014-05-15 2015-05-14 Étalonnage de niveau de substance à analyser à l'aide d'un niveau de substance à analyser de ligne de base
AU2015259020A AU2015259020C1 (en) 2014-05-15 2015-05-14 Analyte level calibration using baseline analyte level
ES15793074T ES2905877T3 (es) 2014-05-15 2015-05-14 Calibración del nivel de analito utilizando el nivel de analito en la línea base
CA2948652A CA2948652C (fr) 2014-05-15 2015-05-14 Etalonnage de niveau de substance a analyser a l'aide d'un niveau de substance a analyser de ligne de base
US15/310,691 US10905364B2 (en) 2014-05-15 2015-05-14 Analyte level calibration using baseline analyte level
RU2016149127A RU2016149127A (ru) 2014-05-15 2015-05-14 Калибровка уровня аналита с использованием базисного уровня аналита
EP21206620.3A EP4026496A1 (fr) 2014-05-15 2015-05-14 Étalonnage du niveau d'analyte au moyen du niveau d'analyte de référence
CN201580025914.6A CN106456065B (zh) 2014-05-15 2015-05-14 使用基线分析物水平的分析物水平校准
US17/149,976 US20210128029A1 (en) 2014-05-15 2021-01-15 Analyte level calibration using baseline analyte level

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201461993908P 2014-05-15 2014-05-15
US61/993,908 2014-05-15

Related Child Applications (2)

Application Number Title Priority Date Filing Date
US15/310,691 A-371-Of-International US10905364B2 (en) 2014-05-15 2015-05-14 Analyte level calibration using baseline analyte level
US17/149,976 Continuation US20210128029A1 (en) 2014-05-15 2021-01-15 Analyte level calibration using baseline analyte level

Publications (1)

Publication Number Publication Date
WO2015175828A1 true WO2015175828A1 (fr) 2015-11-19

Family

ID=54480704

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2015/030880 WO2015175828A1 (fr) 2014-05-15 2015-05-14 Étalonnage de niveau de substance à analyser à l'aide d'un niveau de substance à analyser de ligne de base

Country Status (8)

Country Link
US (2) US10905364B2 (fr)
EP (2) EP4026496A1 (fr)
CN (1) CN106456065B (fr)
AU (1) AU2015259020C1 (fr)
CA (2) CA2948652C (fr)
ES (1) ES2905877T3 (fr)
RU (1) RU2016149127A (fr)
WO (1) WO2015175828A1 (fr)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3923295A1 (fr) * 2009-08-31 2021-12-15 Abbott Diabetes Care, Inc. Dispositifs médicaux et procédés
CN107788994B (zh) * 2017-10-12 2019-10-01 微泰医疗器械(杭州)有限公司 一种基于云端大数据的智能实时动态血糖监测系统及方法
USD1002852S1 (en) * 2019-06-06 2023-10-24 Abbott Diabetes Care Inc. Analyte sensor device

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20070016381A1 (en) * 2003-08-22 2007-01-18 Apurv Kamath Systems and methods for processing analyte sensor data
US20100268477A1 (en) * 2007-10-31 2010-10-21 Medtronic Minimed, Inc. Systems and Methods for Calibrating Physiological Characteristic Sensors
US20120191362A1 (en) * 2009-08-27 2012-07-26 Nikolaus Schmitt Calibration method for the prospective calibration of measuring equipment
US20130325352A1 (en) * 2012-06-05 2013-12-05 Dexcom, Inc. Calculation engine based on histograms
WO2014035732A1 (fr) * 2012-08-30 2014-03-06 Abbot Diabetes Care Inc. Détection de pertes d'information dans des données de surveillance continue d'analyte lors d'excursions des données

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8974386B2 (en) * 1998-04-30 2015-03-10 Abbott Diabetes Care Inc. Analyte monitoring device and methods of use
KR100620257B1 (ko) 1998-11-30 2006-09-13 노보 노르디스크 에이/에스 의료 시스템 및 의학적 자가 치료를 위해 환자에 의해사용되는 시스템의 제어 방법
KR100627990B1 (ko) * 1998-11-30 2006-09-26 노보 노르디스크 에이/에스 복수의 조치를 포함하는 의학적 자가 치료에서 사용자를돕기 위한 방법 및 시스템
US8725535B2 (en) * 2007-04-26 2014-05-13 General Electric Company Systems and methods for user-configurable range settings in clinical information systems
US8287487B2 (en) * 2008-10-15 2012-10-16 Asante Solutions, Inc. Infusion pump system and methods
CN102469966B (zh) * 2009-07-23 2015-05-13 雅培糖尿病护理公司 持续分析物测量系统和用于植入它们的系统和方法
US8543354B2 (en) 2010-06-23 2013-09-24 Medtronic Minimed, Inc. Glucose sensor signal stability analysis
US9402569B2 (en) * 2010-10-28 2016-08-02 Medtronic Minimed, Inc. System and/or method for glucose sensor calibration

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20070016381A1 (en) * 2003-08-22 2007-01-18 Apurv Kamath Systems and methods for processing analyte sensor data
US20100268477A1 (en) * 2007-10-31 2010-10-21 Medtronic Minimed, Inc. Systems and Methods for Calibrating Physiological Characteristic Sensors
US20120191362A1 (en) * 2009-08-27 2012-07-26 Nikolaus Schmitt Calibration method for the prospective calibration of measuring equipment
US20130325352A1 (en) * 2012-06-05 2013-12-05 Dexcom, Inc. Calculation engine based on histograms
WO2014035732A1 (fr) * 2012-08-30 2014-03-06 Abbot Diabetes Care Inc. Détection de pertes d'information dans des données de surveillance continue d'analyte lors d'excursions des données

Also Published As

Publication number Publication date
US20170071513A1 (en) 2017-03-16
AU2015259020B2 (en) 2020-04-09
CN106456065B (zh) 2020-04-03
CA2948652C (fr) 2023-08-29
AU2015259020A1 (en) 2016-11-17
CN106456065A (zh) 2017-02-22
EP3142552A1 (fr) 2017-03-22
EP3142552A4 (fr) 2018-01-24
CA3204700A1 (fr) 2015-11-19
RU2016149127A (ru) 2018-06-20
EP4026496A1 (fr) 2022-07-13
US20210128029A1 (en) 2021-05-06
CA2948652A1 (fr) 2015-11-19
ES2905877T3 (es) 2022-04-12
RU2016149127A3 (fr) 2018-12-04
US10905364B2 (en) 2021-02-02
AU2015259020C1 (en) 2020-10-01
EP3142552B1 (fr) 2021-11-10

Similar Documents

Publication Publication Date Title
US20210128029A1 (en) Analyte level calibration using baseline analyte level
EP1886113B1 (fr) Utilisation de points de donnees multiples d'un filtrage dans un detecteur d'analyte
US8532935B2 (en) Method and device for providing offset model based calibration for analyte sensor
US8083925B2 (en) Analyte determination methods and devices
EP3791788A1 (fr) Détection de fin de vie d'un capteur d'analyte continu
US20080161666A1 (en) Analyte devices and methods
US20140156204A1 (en) Method and Apparatus for Providing Glycemic Control
US20140138261A1 (en) System and method for determination of a concentration of at least one interfering substance and correction of glucose concentration based on the concentration of the interfering substance
US11737688B2 (en) Apparatus and methods of probing sensor operation and/or determining analyte values during continuous analyte sensing
US20100299075A1 (en) Systems and methods for calculating an average analyte concentration value
US20230320631A1 (en) Methods and apparatus for information gathering, error detection and analyte concentration determination during continuous analyte sensing
US11627894B2 (en) Method and a device for determining a body fluid glucose level of a patient, and a computer program product
Isbell et al. Glucose meters: Where are we now? Where are we heading?

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 15793074

Country of ref document: EP

Kind code of ref document: A1

REEP Request for entry into the european phase

Ref document number: 2015793074

Country of ref document: EP

WWE Wipo information: entry into national phase

Ref document number: 2015793074

Country of ref document: EP

ENP Entry into the national phase

Ref document number: 2948652

Country of ref document: CA

WWE Wipo information: entry into national phase

Ref document number: 15310691

Country of ref document: US

NENP Non-entry into the national phase

Ref country code: DE

ENP Entry into the national phase

Ref document number: 2015259020

Country of ref document: AU

Date of ref document: 20150514

Kind code of ref document: A

ENP Entry into the national phase

Ref document number: 2016149127

Country of ref document: RU

Kind code of ref document: A